share_log

Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea

Benzinga ·  Nov 12, 2023 19:06

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment